Abstract
Infants with moderate to severe neonatal encephalopathy (NE) benefit significantly from therapeutic hypothermia, with reduced risk of death or disability. However, the need for therapeutic hypothermia for infants with milder NE remains unclear. It has been suggested that these infants should not be offered therapeutic hypothermia as they may not be at risk for adverse neurodevelopmental outcome and that the balance of risk against potential benefit is unknown. Several key questions need to be answered including first, whether one can define NE in the first 6 h after birth so as to accurately distinguish infants with brain injury who may be at risk for adverse neurodevelopmental consequences. Second, will treatment of infants with mild NE with therapeutic hypothermia improve or even worsen neurological outcomes? Although alternate treatment protocols for mild NE may be feasible, the use of the current approach combined with rigorous avoidance of hyperthermia and initiation of hypothermia as early as possible after birth may promote optimal outcomes. Animal experimental data support the potential for greater benefit for mild HIE compared with moderate to severe HIE. This review will summarize current knowledge of mild NE and the challenges to a trial in this population.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Robertson, C. & Finer, N. Term infants with hypoxic-ischemic encephalopathy: outcome at 3.5 years. Dev. Med. Child Neurol. 27, 473–484 (1985).
Robertson, C. M., Finer, N. N. & Grace, M. G. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J. Pediatr. 114, 753–760 (1989).
Finer, N. N., Robertson, C. M., Peters, K. L. & Coward, J. H. Factors affecting outcome in hypoxic-ischemic encephalopathy in term infants. Am. J. Dis. Child. 137, 21–25 (1983).
Conway, J. M., Walsh, B. H., Boylan, G. B. & Murray, D. M. Mild hypoxic ischaemic encephalopathy and long term neurodevelopmental outcome—a systematic review. Early Hum. Dev. 120, 80–87 (2018).
Chalak, L., Latremouille, S., Mir, I., Sanchez, P. J. & Sant’Anna, G. A review of the conundrum of mild hypoxic-ischemic encephalopathy: current challenges and moving forward. Early Hum. Dev. 120, 88–94 (2018).
Wassink, G. et al. Analgesics, sedatives, anticonvulsant drugs, and the cooled brain. Semin. Fetal Neonatal Med. 20, 109–114 (2015).
Prempunpong, C. et al. Prospective research on infants with mild encephalopathy: the PRIME study. J. Perinatol. 38, 80–85 (2018).
Jary, S., Whitelaw, A., Walloe, L. & Thoresen, M. Comparison of Bayley-2 and Bayley-3 scores at 18 months in term infants following neonatal encephalopathy and therapeutic hypothermia. Dev. Med. Child Neurol. 55, 1053–1059 (2013).
van Handel, M., Swaab, H., de Vries, L. S. & Jongmans, M. J. Behavioral outcome in children with a history of neonatal encephalopathy following perinatal asphyxia. J. Pediatr. Psychol. 35, 286–295 (2010).
Odd, D. E., Lewis, G., Whitelaw, A. & Gunnell, D. Resuscitation at birth and cognition at 8 years of age: a cohort study. Lancet 373, 1615–1622 (2009).
Murray, D. M., O’Connor, C. M., Ryan, C. A., Korotchikova, I. & Boylan, G. B. Early EEG grade and outcome at 5 years after mild neonatal hypoxic ischemic encephalopathy. Pediatrics 138, e20160659 (2016).
Jacobs, S. E. et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch. Pediatr. Adolesc. Med. 165, 692–700 (2011).
Zhou, W. H. et al. Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China. J. Pediatr. 157, 367–372 (2010).
Battin, M. R., Dezoete, J. A., Gunn, T. R., Gluckman, P. D. & Gunn, A. J. Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatrics 107, 480–484 (2001).
Wyatt, J. S. et al. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics 119, 912–921 (2007).
Chalak, L. F. et al. Prospective research in infants with mild encephalopathy identified in the first six hours of life: neurodevelopmental outcomes at 18-22 months. Pediatr. Res. 84, 861–868 (2018).
Jacobs, S. E. et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst. Rev. 1, CD003311 (2013).
Lally, P. J. et al. Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multi-centre study. Lancet Neurol. 18, 35–45 (2019).
Sarnat, H. B. & Sarnat, M. S. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch. Neurol. 33, 696–705 (1976).
Thompson, C. M. et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 86, 757–761 (1997).
Gagne-Loranger, M., Sheppard, M., Ali, N., Saint-Martin, C. & Wintermark, P. Newborns referred for therapeutic hypothermia: association between initial degree of encephalopathy and severity of brain injury (What about the newborns with mild Encephalopathy on admission?). Am. J. Perinatol. 33, 195–202 (2016).
Walsh, B. H. et al. The frequency and severity of magnetic resonance imaging abnormalities in infants with mild neonatal encephalopathy. J. Pediatr. 187, 26–33.e21 (2017).
Soll, R. F. Cooling for newborns with hypoxic ischemic encephalopathy. Neonatology 103, 261 (2013).
Azzopardi, D. et al. Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK—analysis of national data. PLoS ONE 7, e38504 (2012).
Kracer, B., Hintz, S. R., Van Meurs, K. P. & Lee, H. C. Hypothermia therapy for neonatal hypoxic ischemic encephalopathy in the state of California. J. Pediatr. 165, 267–273 (2014).
Massaro, A. N. et al. Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children’s Hospitals Neonatal Consortium HIE focus group. J. Perinatol. 35, 290–296 (2015).
Thayyil, S. et al. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics 125, e382–e395 (2010).
Wassink, G. et al. A working model for hypothermic neuroprotection. J. Physiol. 596, 5641–5654 (2018).
Gunn, A. J. & Bennet, L. Fetal hypoxia insults and patterns of brain injury: Insights from animal models. Clin. Perinatol. 36, 579–593 (2009).
Gunn, A. J., Gunn, T. R., de Haan, H. H., Williams, C. E. & Gluckman, P. D. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J. Clin. Invest. 99, 248–256 (1997).
Gunn, A. J., Parer, J. T., Mallard, E. C., Williams, C. E. & Gluckman, P. D. Cerebral histologic and electrocorticographic changes after asphyxia in fetal sheep. Pediatr. Res. 31, 486–491 (1992).
de Haan, H. H., van Reempts, J. L., Vles, J. S., de Haan, J. & Hasaart, T. H. Effects of asphyxia on the fetal lamb brain. Am. J. Obstet. Gynecol. 169, 1493–1501 (1993).
Ikeda, T. et al. Physiologic and histologic changes in near-term fetal lambs exposed to asphyxia by partial umbilical cord occlusion. Am. J. Obstet. Gynecol. 178, 24–32 (1998).
de Haan, H. H., Gunn, A. J., Williams, C. E. & Gluckman, P. D. Brief repeated umbilical cord occlusions cause sustained cytotoxic cerebral edema and focal infarcts in near-term fetal lambs. Pediatr. Res. 41, 96–104 (1997).
Okereafor, A. et al. Patterns of brain injury in neonates exposed to perinatal sentinel events. Pediatrics 121, 906–914 (2008).
Drury, P. P. et al. Status epilepticus after prolonged umbilical cord occlusion is associated with greater neural injury in fetal sheep at term-equivalent. PLoS ONE 9, e96530 (2014).
Mallard, E. C., Gunn, A. J., Williams, C. E., Johnston, B. M. & Gluckman, P. D. Transient umbilical cord occlusion causes hippocampal damage in the fetal sheep. Am. J. Obstet. Gynecol. 167, 1423–1430 (1992).
Williams, C. E., Gunn, A. J., Mallard, C. & Gluckman, P. D. Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study. Ann. Neurol. 31, 14–21 (1992).
Beilharz, E. J., Williams, C. E., Dragunow, M., Sirimanne, E. S. & Gluckman, P. D. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Mol. Brain Res. 29, 1–14 (1995).
Colbourne, F. & Corbett, D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 654, 265–272 (1994).
Colbourne, F. & Corbett, D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J. Neurosci. 15, 7250–7260 (1995).
Colbourne, F., Corbett, D., Zhao, Z., Yang, J. & Buchan, A. M. Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model. J. Cereb. Blood Flow Metab. 20, 1702–1708 (2000).
Sabir, H., Scull-Brown, E., Liu, X. & Thoresen, M. Immediate hypothermia is not neuroprotective after severe hypoxia-ischemia and is deleterious when delayed by 12 h in neonatal rats. Stroke 43, 3364–3370 (2012).
Bona, E., Hagberg, H., Loberg, E. M., Bagenholm, R. & Thoresen, M. Protective effects of moderate hypothermia after neonatal hypoxia- ischemia: short- and long-term outcome. Pediatr. Res. 43, 738–745 (1998).
Colbourne, F., Sutherland, G. & Corbett, D. Postischemic hypothermia. A critical appraisal with implications for clinical treatment. Mol. Neurobiol. 14, 171–201 (1997).
Wood, T. et al. Treatment temperature and insult severity influence the neuroprotective effects of therapeutic hypothermia. Sci. Rep. 6, 23430 (2016).
Davidson, J. O. et al. How long is sufficient for optimal neuroprotection with cerebral cooling after ischemia in fetal sheep? J. Cereb. Blood. Flow. Metab. 38, 1047–1059 (2018).
Osredkar, D. et al. Hypothermia is not neuroprotective after infection-sensitized neonatal hypoxic-ischemic brain injury. Resuscitation 85, 567–572 (2014).
Mir, I. N. et al. Placental pathology is associated with severity of neonatal encephalopathy and adverse developmental outcomes following hypothermia. Am. J. Obstet. Gynecol. 213, 849 e841–847 (2015).
Hakobyan, M. et al. Outcome of infants with therapeutic hypothermia after perinatal asphyxia and early-onset sepsis. Neonatology 115, 127–133 (2018).
Murray, D. M. et al. The predictive value of early neurological examination in neonatal hypoxic-ischaemic encephalopathy and neurodevelopmental outcome at 24 months. Dev. Med. Child Neurol. 52, e55–e59 (2010).
Shalak, L. F., Laptook, A. R., Velaphi, S. C. & Perlman, J. M. Amplitude-integrated electroencephalography coupled with an early neurologic examination enhances prediction of term infants at risk for persistent encephalopathy. Pediatrics 111, 351–357 (2003).
Azzopardi, D. V. et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N. Engl. J. Med. 361, 1349–1358 (2009).
Gluckman, P. D. et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365, 663–670 (2005).
Shankaran, S. et al. Evolution of encephalopathy during whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. J. Pediatr. 160, 567–572 e563 (2012).
Perez, J. M., Golombek, S. G. & Sola, A. Clinical hypoxic-ischemic encephalopathy score of the Iberoamerican Society of Neonatology (Siben): a new proposal for diagnosis and management. Rev. Assoc. Med Bras. (1992) 63, 64–69 (2017).
Hossmann, K. A. Pathophysiology and therapy of experimental stroke. Cell. Mol. Neurobiol. 26, 1057–1083 (2006).
Vesoulis, Z. A. et al. Re-examining the arterial cord blood gas pH screening criteria in neonatal encephalopathy. Arch. Dis. Child. Fetal Neonatal Ed. 103, F377–F382 (2018).
Chakkarapani, E., Davis, J. & Thoresen, M. Therapeutic hypothermia delays the C-reactive protein response and suppresses white blood cell and platelet count in infants with neonatal encephalopathy. Arch. Dis. Child. Fetal Neonatal Ed. 99, F458–F463 (2014).
Celik, I. H. et al. What are the cut-off levels for IL-6 and CRP in neonatal sepsis? J. Clin. Lab. Anal. 24, 407–412 (2010).
Karlsson, M. et al. Lactate dehydrogenase predicts hypoxic ischaemic encephalopathy in newborn infants: a preliminary study. Acta Paediatr. 99, 1139–1144 (2010).
Thoresen, M. et al. Lactate dehydrogenase in hypothermia-treated newborn infants with hypoxic-ischaemic encephalopathy. Acta Paediatr. 101, 1038–1044 (2012).
Graham, E. M., Burd, I., Everett, A. D. & Northington, F. J. Blood biomarkers for evaluation of perinatal encephalopathy. Front. Pharmacol. 7, 196 (2016).
Mir, I. N. & Chalak, L. F. Serum biomarkers to evaluate the integrity of the neurovascular unit. Early Hum. Dev. 90, 707–711 (2014).
Hellstrom-Westas, L., Rosen, I. & Svenningsen, N. W. Predictive value of early continuous amplitude integrated EEG recordings on outcome after severe birth asphyxia in full term infants. Arch. Dis. Child. Fetal Neonatal Ed. 72, F34–F38 (1995).
al Naqeeb, N., Edwards, A. D., Cowan, F. M. & Azzopardi, D. Assessment of neonatal encephalopathy by amplitude-integrated electroencephalography. Pediatrics 103, 1263–1271 (1999).
Thoresen, M., Hellstrom-Westas, L., Liu, X. & de Vries, L. S. Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 126, e131–e139 (2010).
Skranes, J. H. et al. Amplitude-integrated electroencephalography improves the identification of infants with encephalopathy for therapeutic hypothermia and predicts neurodevelopmental outcomes at 2 years of age. J. Pediatr. 187, 34–42 (2017).
Liu, X., Jary, S., Cowan, F. & Thoresen, M. Reduced infancy and childhood epilepsy following hypothermia-treated neonatal encephalopathy. Epilepsia 58, 1902–1911 (2017).
Azzopardi, D. et al. Treatment of asphyxiated newborns with moderate hypothermia in routine clinical practice: how cooling is managed in the UK outside a clinical trial. Arch. Dis. Child. Fetal Neonatal Ed. 94, F260–F264 (2009).
Azzopardi, D. Predictive value of the amplitude integrated EEG in infants with hypoxic ischaemic encephalopathy: data from a randomised trial of therapeutic hypothermia. Arch. Dis. Child. Fetal Neonatal Ed. 99, F80–F82 (2014).
Walsh, B. H. & Inder, T. E. MRI as a biomarker for mild neonatal encephalopathy. Early Hum. Dev. 120, 75–79 (2018).
Thoresen, M. et al. Time is brain: starting therapeutic hypothermia within three hours after birth improves motor outcome in asphyxiated newborns. Neonatology 104, 228–233 (2013).
Acknowledgements
The work reported in this review was supported in part by The Norwegian Research Council, the Moulton Foundation UK, and Health Research Council of New Zealand and the Neurological Foundation of New Zealand.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
El-Dib, M., Inder, T.E., Chalak, L.F. et al. Should therapeutic hypothermia be offered to babies with mild neonatal encephalopathy in the first 6 h after birth?. Pediatr Res 85, 442–448 (2019). https://doi.org/10.1038/s41390-019-0291-1
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41390-019-0291-1
This article is cited by
-
Racial disparities and outcomes in neonatal hypoxic-ischemic encephalopathy
Journal of Perinatology (2025)
-
Changes in the treatment and outcomes of different severities of neonatal hypoxic ischemic encephalopathy in California: a retrospective cohort study
Journal of Perinatology (2025)
-
Shifting outlooks after neonatal encephalopathy in the era of therapeutic hypothermia
Pediatric Research (2025)
-
Establishing a regional registry for neonatal encephalopathy: impact on identification of gaps in practice
Pediatric Research (2024)
-
Regional variability in therapeutic hypothermia eligibility criteria for neonatal hypoxic-ischemic encephalopathy
Pediatric Research (2024)
